Jorge Reis-Filho, MD, PhD, FRCPath

Jorge Reis-Filho, MD, PhD, FRCPath

Venture Partner atForesite CapitalCalifornia

Jorge Reis-Filho is a Venture Partner at Foresite Labs, focusing on AI and biomedicine strategy. He previously held leadership roles at AstraZeneca and Memorial Sloan Kettering Cancer Center.

What Jorge can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Memorial Sloan Kettering Cancer Center · Chief of Experimental Pathology and Director of the Experimental Pathology Fellowship Program
  2. AstraZeneca · Chief of AI for Science Innovation and Chief AI and Data Scientist for Oncology Research and Development
  3. Foresite Labs · Venture Partner
  4. Foresite Capital · Venture Partner
    Now

Focus

aibiomedicineprecision medicinecompany creation

Also at Foresite Capital

Partners like Jorge

At firms with a similar stage, sector and check size.

Alert me when Foresite Capital is active

One email when Jorge's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Jorge Reis-Filho, MD, PhD, FRCPath?

Jorge Reis-Filho is a Venture Partner at Foresite Labs, focusing on AI and biomedicine strategy. He previously held leadership roles at AstraZeneca and Memorial Sloan Kettering Cancer Center.

How much does Jorge Reis-Filho, MD, PhD, FRCPath invest?

Foresite Capital has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Jorge Reis-Filho, MD, PhD, FRCPath?

A warm intro from a founder Foresite Capital backed works best.

What did Jorge Reis-Filho, MD, PhD, FRCPath do before Foresite Capital?

Chief of Experimental Pathology and Director of the Experimental Pathology Fellowship Program at Memorial Sloan Kettering Cancer Center; Chief of AI for Science Innovation and Chief AI and Data Scientist for Oncology Research and Development at AstraZeneca; Venture Partner at Foresite Labs.

Last updated 2026-10-15. Is this you? Ask for a correction.